JAGX - Jaguar Health Inc
0.491
-0.100 -20.265%
Share volume: 1,211,987
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$0.59
-0.10
-0.17%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 05-15-2025 | 08-14-2025 | 11-14-2025 | |
| Total revenue | 2.351 M | 2.721 M | 3.108 M | 2.214 M | 2.979 M | 3.083 M | |
| Cost of revenue | 430.000 K | 427.000 K | 541.000 K | 515.000 K | 527.000 K | 532.000 K | |
| Gross profit | 1.921 M | 2.294 M | 2.567 M | 1.699 M | 2.452 M | 2.551 M | |
| 19.42% | 11.90% | -33.81% | 44.32% | 4.04% | |||
| Operating expenses | 8.693 M | 7.967 M | 7.819 M | 8.627 M | 7.992 M | 7.792 M | |
| Selling general and admin | 4.381 M | 4.314 M | 3.776 M | 4.897 M | 4.727 M | 4.134 M | |
| Research and development | 4.312 M | 3.653 M | 4.043 M | 3.730 M | 3.265 M | 3.658 M | |
| Total expenses | 10.136 M | 9.491 M | 9.829 M | 11.120 M | 10.459 M | 9.789 M | |
| -6.36% | 3.56% | 13.13% | -5.94% | -6.41% | |||
| Operating income | -8.215 M | -7.197 M | -7.262 M | -9.421 M | -8.007 M | -7.238 M | |
| Ebit | -10.002 M | -9.736 M | -10.183 M | -10.652 M | -8.753 M | -9.642 M | |
| Pretax income | -9.368 M | -9.628 M | -10.021 M | -10.596 M | -10.560 M | -9.648 M | |
| 2.78% | 4.08% | 5.74% | -0.34% | -8.64% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -9.368 M | -9.628 M | -10.021 M | -10.596 M | -10.560 M | -9.648 M | |
| -2.78% | -4.08% | -5.74% | 0.34% | 8.64% |